Patent ID: 8389535
Filing Date: 2013-03-05
Classification: A61K,A61P

Abstract:
1. A method of treating attention deficit disorder with or without hyper-activity in a subject, comprising the steps of: (a) administering a daily dose of L-methylfolate or a pharmacological hydrate or salt thereof to the subject from a treatment day 1 to about a treatment day 7, the daily dose being in the range of 5 mg to 15 mg of said L-methylfolate or pharmacological hydrate or salt thereof depending on the weight of the subject; (b) increasing the daily dose of L-methylfolate or pharmacological hydrate or salt thereof administered to the subject in response to an observed decrease in behavioral or neurological symptoms associated with the subject's attention deficit disorder, the increase in the daily dose of the L-methylfolate or pharmacological hydrate or salt thereof occurring from about treatment day 7 to about a treatment day 30 and resulting in a daily achieved dose of L-methylfolate or pharmacological hydrate or salt thereof at about treatment day 30.